139 related articles for article (PubMed ID: 8298148)
1. Response criteria with fludarabine therapy in chronic lymphocytic leukemia.
Rai KR
Blood; 1994 Feb; 83(3):875-6. PubMed ID: 8298148
[No Abstract] [Full Text] [Related]
2. Fludarabine approved for use in chronic lymphocytic leukemia.
Oncology (Williston Park); 1991 Jun; 5(6):20. PubMed ID: 1831638
[No Abstract] [Full Text] [Related]
3. Fludarabine for chronic lymphocytic leukemia.
Erman M; Celik I; Tekuzman G
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
[No Abstract] [Full Text] [Related]
4. Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia.
Castagna L; Sarina B; Santoro A
Blood; 2003 Sep; 102(6):2309; author reply 2309-10. PubMed ID: 12959942
[No Abstract] [Full Text] [Related]
5. Delayed and long-lasting complete response to fludarabine in two patients with B-cell chronic lymphocytic leukemia.
Zaja F; Russo D; Marin L; Silvestri F; Ramello M; Baccarani M
Ann Hematol; 1999 Sep; 78(9):435-6. PubMed ID: 10525833
[No Abstract] [Full Text] [Related]
6. 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
Schirmer M; Michlmayr G; Geisen F; Konwalinka G
Leukemia; 1996 Jul; 10(7):1253-4. PubMed ID: 8684013
[No Abstract] [Full Text] [Related]
7. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
8. Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
Roberts JD; Smith MR; Feldman EJ; Cragg L; Grant S
Clin Lymphoma; 2002 Dec; 3(3):184-8. PubMed ID: 12521398
[No Abstract] [Full Text] [Related]
9. Fludarabine.
Med Lett Drugs Ther; 1991 Sep; 33(853):89-90. PubMed ID: 1886506
[No Abstract] [Full Text] [Related]
10. Fludarabine for chronic lymphocytic leukemia.
Marchetti M; Barosi G; Liberato LN
N Engl J Med; 2001 Apr; 344(15):1166-7; author reply 1167-8. PubMed ID: 11302140
[No Abstract] [Full Text] [Related]
11. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
Byrd JC; Rai KR
Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
[No Abstract] [Full Text] [Related]
12. Visceral varicella in a patient with chronic lymphocytic leukemia treated with fludarabine: a case report.
Freedberg DE; Bhadelia N; Poneros JM; Oster MW
Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):90-2. PubMed ID: 23103084
[No Abstract] [Full Text] [Related]
13. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
[No Abstract] [Full Text] [Related]
14. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
Hamblin TJ; Orchard JA; Myint H; Oscier DG
J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
[No Abstract] [Full Text] [Related]
15. Oral fludarabine: a viewpoint by David Oscier.
Oscier D
Drugs; 2003; 63(21):2324-5. PubMed ID: 14524735
[No Abstract] [Full Text] [Related]
16. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
Pawelski S
Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
[TBL] [Abstract][Full Text] [Related]
17. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
[No Abstract] [Full Text] [Related]
18. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
Delannoy A; Hanique G; Ferrant A
N Engl J Med; 1993 Mar; 328(11):812; author reply 813. PubMed ID: 8094888
[No Abstract] [Full Text] [Related]
19. Fludarabine treatment and transfusion-associated graft-versus-host disease.
Saven A
Lancet; 1996 Aug; 348(9025):473. PubMed ID: 8709797
[No Abstract] [Full Text] [Related]
20. Oral fludarabine in untreated patients with B-cell chronic lymphocytic leukemia.
Shustik C; Turner AR; Desjardins P; Fernandez L; Rubin S; Larratt L; Duncan AM; Rizi D; Sadura A; Shepherd L; Li D; Rassenti L; Kipps T
Leukemia; 2010 Jan; 24(1):237-9. PubMed ID: 19812607
[No Abstract] [Full Text] [Related]
[Next] [New Search]
